Literature DB >> 32079644

Increased reporting of fatal pneumonitis associated with immune checkpoint inhibitors: a WHO pharmacovigilance database analysis.

Melissa Y Y Moey1, Paul Gougis2, Vincent Goldschmidt2, Douglas B Johnson3, Bénédicte Lebrun-Vignes2,3, Javid Moslehi4, Jacques Cadranel5, Joe-Elie Salem2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32079644     DOI： 10.1183/13993003.00038-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

Review 1.  Harnessing big data to characterize immune-related adverse events.

Authors:  Ying Jing; Jingwen Yang; Douglas B Johnson; Javid J Moslehi; Leng Han
Journal:  Nat Rev Clin Oncol       Date:  2022-01-17       Impact factor: 65.011

Review 2.  Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.

Authors:  Javid Moslehi; Andrew H Lichtman; Arlene H Sharpe; Lorenzo Galluzzi; Richard N Kitsis
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

3.  Vascular Normalization to Improve Treatment of COVID-19: Lessons from Treatment of Cancer.

Authors:  Lance L Munn; Triantafyllos Stylianopoulos; Natalie K Jain; C Corey Hardin; Melin J Khandekar; Rakesh K Jain
Journal:  Clin Cancer Res       Date:  2021-03-01       Impact factor: 13.801

4.  Multidisciplinary Approach of Immune Checkpoint Inhibitor-Related Pneumonitis: A Key to Address Knowledge and Management Gaps.

Authors:  Maurice Pérol
Journal:  J Thorac Oncol       Date:  2020-08       Impact factor: 15.609

Review 5.  The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review.

Authors:  Alistair R Miller; Renee Manser
Journal:  Transl Lung Cancer Res       Date:  2021-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.